Page last updated: 2024-10-25

desipramine and Carcinoma, Small Cell

desipramine has been researched along with Carcinoma, Small Cell in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research Excerpts

ExcerptRelevanceReference
"Human neuroblastoma cells of sympathetic origin have been used for studying the effects of diosmin and its metabolite diosmetin (vasotonic agent) on amine reuptake systems."3.68Amine uptake inhibition by diosmin and diosmetin in human neuronal and neuroendocrine cell lines. ( Biancardi, E; Clementi, F; Codignola, A; Cova, D; Sher, E, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sher, E1
Codignola, A1
Biancardi, E1
Cova, D1
Clementi, F1

Other Studies

1 other study available for desipramine and Carcinoma, Small Cell

ArticleYear
Amine uptake inhibition by diosmin and diosmetin in human neuronal and neuroendocrine cell lines.
    Pharmacological research, 1992, Volume: 26, Issue:4

    Topics: Biogenic Monoamines; Carcinoma, Small Cell; Cell Line; Cell Membrane; Desipramine; Diosmin; Dopamine

1992